J Proteome Res. 2005 Jul-Aug;4(4):1104-9.

Perspective: a program to improve protein biomarker discovery for cancer.

Aebersold R, Anderson L, Caprioli R, Druker B, Hartwell L, Smith R.

Source

Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue, North, PO Box 19024, Seattle, WA 98109-1024, USA.

Abstract

Biomarkers for cancer risk, early detection, prognosis, and therapeutic response promise to revolutionize cancer management. Protein biomarkers offer tremendous potential in this regard due to their great diversity and intimate involvement in physiology. An effective program to discover protein biomarkers using existing technology will require team science, an integrated informatics platform, identification and quantitation of candidate biomarkers in disease tissue, mouse models of disease, standardized reagents for analyzing candidate biomarkers in bodily fluids, and implementation of automation. Technology improvements for better fractionation of the proteome, selection of specific biomarkers from complex mixtures, and multiplexed assay of biomarkers would greatly enhance progress.

PMID:: 16083259; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Cancer - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Review New cancer biomarkers deriving from NCI early detection research. [Recent Results Cancer Res. 2003]
Review New cancer biomarkers deriving from NCI early detection research.
Verma M, Srivastava S. Recent Results Cancer Res. 2003; 163:72-84; discussion 264-6.
Review Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers. [Adv Cancer Res. 2007]
Review Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
Lee JW, Figeys D, Vasilescu J. Adv Cancer Res. 2007; 96:269-98.
Clinical proteomics and biomarker discovery. [Ann N Y Acad Sci. 2004]
Clinical proteomics and biomarker discovery.
Johann DJ Jr, McGuigan MD, Patel AR, Tomov S, Ross S, Conrads TP, Veenstra TD, Fishman DA, Whiteley GR, Petricoin EF 3rd, et al. Ann N Y Acad Sci. 2004 Jun; 1022:295-305.
Review Proteomics of cancer of hormone-dependent tissues. [Adv Exp Med Biol. 2008]
Review Proteomics of cancer of hormone-dependent tissues.
Tyson DR, Ornstein DK. Adv Exp Med Biol. 2008; 630:133-47.
Review Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy. [Biosci Rep. 2005]
Review Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
Calvo KR, Liotta LA, Petricoin EF. Biosci Rep. 2005 Feb-Apr; 25(1-2):107-25.

See reviews... See all...

Cited by 18 PubMed Central articles

Biomarker analysis of stored blood products: emphasis on pre-analytical issues. [Int J Mol Sci. 2010]
Biomarker analysis of stored blood products: emphasis on pre-analytical issues.
Delobel J, Rubin O, Prudent M, Crettaz D, Tissot JD, Lion N. Int J Mol Sci. 2010 Nov 17; 11(11):4601-17. Epub 2010 Nov 17.
Differential profiling of breast cancer plasma proteome by isotope-coded affinity tagging method reveals biotinidase as a breast cancer biomarker. [BMC Cancer. 2010]
Differential profiling of breast cancer plasma proteome by isotope-coded affinity tagging method reveals biotinidase as a breast cancer biomarker.
Kang UB, Ahn Y, Lee JW, Kim YH, Kim J, Yu MH, Noh DY, Lee C. BMC Cancer. 2010 Mar 26; 10:114. Epub 2010 Mar 26.
Review Nanoparticle technology: addressing the fundamental roadblocks to protein biomarker discovery. [Curr Mol Med. 2010]
Review Nanoparticle technology: addressing the fundamental roadblocks to protein biomarker discovery.
Luchini A, Fredolini C, Espina BH, Meani F, Reeder A, Rucker S, Petricoin EF 3rd, Liotta LA. Curr Mol Med. 2010 Mar; 10(2):133-41.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Perspective: a program to improve protein biomarker discovery for cancer.
Perspective: a program to improve protein biomarker discovery for cancer.
J Proteome Res. 2005 Jul-Aug ;4(4):1104-9.

PubMed
SCORPIO: a system of medical teaching.
SCORPIO: a system of medical teaching.
Med Teach. 1992 ;14(1):37-41.

PubMed
An evaluation of the Beckman-Coulter AcT 3-part differential haematology analyze...
An evaluation of the Beckman-Coulter AcT 3-part differential haematology analyzer in a tertiary hospital laboratory.
Niger J Med. 2005 Apr-Jun ;14(2):183-7.

PubMed
Hospital-based epidemiology of childhood cholera: a 6-year review in a universit...
Hospital-based epidemiology of childhood cholera: a 6-year review in a university hospital in Bangkok, Thailand.
J Med Assoc Thai. 2004 Sep ;87 Suppl 2:S59-61.

PubMed
Hyperalgesia and opioid switching.
Hyperalgesia and opioid switching.
Am J Hosp Palliat Care. 2005 Jul-Aug ;22(4):291-4.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: